Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968356 · ClinicalTrials.gov registry record · Phase 3
In-vivo Efficacy Study of Patient Preoperative Preps
A Phase 3 study, sponsored by Solventum US.
- Terminated
- Registry status
- Phase 3
- Development phase
- 171
- Enrollment target
NCT01968356 is a Phase 3 study that was terminated before completion, run by Solventum US. The registered enrollment target is 171 participants.
The verdict
NCT01968356, a Phase 3 study, was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 171 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
Interventions
- DRUG Saline
- DRUG ChloraPrep
- DRUG 3M CHG/IPA Prep Colorless
- DRUG 3M CHG/IPA Prep Tint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01968356
The ClinicalTrials.gov registry entry for NCT01968356 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Saline is the first listed.
NCT01968356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01968356 about?
NCT01968356 is a clinical study titled "In-vivo Efficacy Study of Patient Preoperative Preps". The purpose of this study is to evaluate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
What is the current status of trial NCT01968356?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 171 participants. The study started on 2013-10. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01968356?
The interventions under investigation include: Saline (DRUG), ChloraPrep (DRUG), 3M CHG/IPA Prep Colorless (DRUG), 3M CHG/IPA Prep Tint (DRUG).
Who is sponsoring clinical trial NCT01968356?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.